$BCPC
BALCHEM CORP

2023 Q2 Form 10-Q Financial Statement

#000162828023014088 Filed on April 28, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $231.3M $232.5M $228.9M
YoY Change -2.3% 1.6% 23.27%
Cost Of Revenue $153.9M $159.4M $157.4M
YoY Change -6.62% 1.28% 23.98%
Gross Profit $77.35M $73.17M $71.51M
YoY Change 7.61% 2.33% 21.76%
Gross Profit Margin 33.45% 31.47% 31.24%
Selling, General & Admin $32.14M $35.31M $29.94M
YoY Change 10.69% 17.95% 17.86%
% of Gross Profit 41.55% 48.26% 41.87%
Research & Development $3.795M $3.450M $3.231M
YoY Change 29.88% 6.78% 17.53%
% of Gross Profit 4.91% 4.72% 4.52%
Depreciation & Amortization $13.43M $13.65M $11.93M
YoY Change 12.53% 14.4% -3.53%
% of Gross Profit 17.36% 18.65% 16.68%
Operating Expenses $35.93M $38.76M $33.17M
YoY Change 12.44% 16.86% 17.82%
Operating Profit $41.42M $34.41M $38.34M
YoY Change 3.75% -10.25% 25.38%
Interest Expense -$5.302M -$5.704M -$685.0K
YoY Change 382.0% 732.7% 14.17%
% of Operating Profit -12.8% -16.58% -1.79%
Other Income/Expense, Net $866.0K -$5.289M -$706.0K
YoY Change -230.82% 649.15% 19.26%
Pretax Income $38.40M $29.12M $37.63M
YoY Change -2.19% -22.62% 25.5%
Income Tax $8.290M $6.409M $8.700M
% Of Pretax Income 21.59% 22.01% 23.12%
Net Earnings $30.11M $22.71M $28.93M
YoY Change 1.1% -21.5% 23.57%
Net Earnings / Revenue 13.02% 9.77% 12.64%
Basic Earnings Per Share $0.94 $0.71 $0.90
Diluted Earnings Per Share $0.93 $0.70 $0.89
COMMON SHARES
Basic Shares Outstanding 32.23M shares 32.17M shares 32.04M shares
Diluted Shares Outstanding 32.43M shares 32.42M shares 32.48M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $66.86M $60.20M $64.47M
YoY Change -12.24% -6.62% -27.16%
Cash & Equivalents $66.86M $60.20M $64.47M
Short-Term Investments
Other Short-Term Assets $19.62M $7.878M $4.570M
YoY Change 238.51% 72.39% 18.82%
Inventory $124.9M $124.8M $108.4M
Prepaid Expenses
Receivables $125.1M $131.4M $137.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $336.5M $335.6M $319.8M
YoY Change -10.77% 4.94% 13.73%
LONG-TERM ASSETS
Property, Plant & Equipment $289.8M $276.1M $240.4M
YoY Change 14.94% 14.84% 6.14%
Goodwill $773.9M $774.4M $522.6M
YoY Change 5.76% 48.18% -0.7%
Intangibles
YoY Change
Long-Term Investments $4.089M $4.212M $4.417M
YoY Change -6.04% -4.64% -7.98%
Other Assets $11.90M $15.72M $13.48M
YoY Change -14.02% 16.56% 4.63%
Total Long-Term Assets $1.283B $1.293B $875.1M
YoY Change 4.32% 47.77% -1.45%
TOTAL ASSETS
Total Short-Term Assets $336.5M $335.6M $319.8M
Total Long-Term Assets $1.283B $1.293B $875.1M
Total Assets $1.619B $1.629B $1.195B
YoY Change 0.78% 36.31% 2.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $56.32M $53.42M $46.82M
YoY Change -15.13% 14.1% 38.52%
Accrued Expenses $57.65M $42.75M $53.96M
YoY Change -1.71% -20.76% 44.27%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $232.0K $229.0K $169.0K
YoY Change 35.67% 35.5% -15.5%
Total Short-Term Liabilities $114.4M $116.5M $123.5M
YoY Change -20.64% -5.67% 39.17%
LONG-TERM LIABILITIES
Long-Term Debt $407.7M $433.7M $130.8M
YoY Change -6.45% 231.52% -16.14%
Other Long-Term Liabilities $28.43M $42.18M $19.84M
YoY Change -40.53% 112.66% -14.13%
Total Long-Term Liabilities $436.1M $475.9M $150.7M
YoY Change -9.82% 215.87% -15.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.4M $116.5M $123.5M
Total Long-Term Liabilities $436.1M $475.9M $150.7M
Total Liabilities $612.3M $655.3M $321.2M
YoY Change -13.18% 104.01% 0.47%
SHAREHOLDERS EQUITY
Retained Earnings $867.3M $837.2M $761.1M
YoY Change 9.67% 10.0% 11.9%
Common Stock $2.151M $2.150M $2.142M
YoY Change 0.37% 0.37% -1.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.007B $973.4M $873.7M
YoY Change
Total Liabilities & Shareholders Equity $1.619B $1.629B $1.195B
YoY Change 0.78% 36.31% 2.2%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $30.11M $22.71M $28.93M
YoY Change 1.1% -21.5% 23.57%
Depreciation, Depletion And Amortization $13.43M $13.65M $11.93M
YoY Change 12.53% 14.4% -3.53%
Cash From Operating Activities $34.99M $34.84M $7.021M
YoY Change -27.46% 396.2% -82.71%
INVESTING ACTIVITIES
Capital Expenditures $8.232M $9.612M $9.709M
YoY Change -178.08% -1.0% 63.15%
Acquisitions $341.0K $0.00
YoY Change
Other Investing Activities $4.621M -$341.0K $184.0K
YoY Change -101.56% -285.33% 84.0%
Cash From Investing Activities -$3.611M -$10.06M -$10.07M
YoY Change -98.82% -0.11% 61.77%
FINANCING ACTIVITIES
Cash Dividend Paid $22.87M $20.70M
YoY Change 10.45% 10.71%
Common Stock Issuance & Retirement, Net $34.60M
YoY Change 2067.86%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.76M -$33.32M -$34.85M
YoY Change -109.02% -4.38% 24.74%
NET CHANGE
Cash From Operating Activities 34.99M $34.84M $7.021M
Cash From Investing Activities -3.611M -$10.06M -$10.07M
Cash From Financing Activities -24.76M -$33.32M -$34.85M
Net Change In Cash 6.621M -$6.361M -$38.77M
YoY Change -59.72% -83.59% -1078.13%
FREE CASH FLOW
Cash From Operating Activities $34.99M $34.84M $7.021M
Capital Expenditures $8.232M $9.612M $9.709M
Free Cash Flow $26.76M $25.23M -$2.688M
YoY Change -54.48% -1038.47% -107.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000009326
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 bcpc Percentage Of Operating Expenses To Be Absorbed
PercentageOfOperatingExpensesToBeAbsorbed
0.6666
CY2023Q1 bcpc Percentage Of Production Offtake
PercentageOfProductionOfftake
0.6666
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-13648
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Balchem Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-2578432
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5 Paragon Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Montvale
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07645
CY2023Q1 dei City Area Code
CityAreaCode
845
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
326-5600
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $.06-2/3 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
BCPC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32227733 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60199000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66560000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1260000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1226000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
131369000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
131578000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
124768000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
119668000 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
7425000 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
4903000 usd
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
3964000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
5993000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
7878000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
7101000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
335603000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
335803000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
276103000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
271355000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
774361000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
769509000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
209470000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
213295000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15232000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17094000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2281000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2338000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15715000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15118000 usd
CY2023Q1 us-gaap Assets
Assets
1628765000 usd
CY2022Q4 us-gaap Assets
Assets
1624512000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
53419000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
57322000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42754000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36745000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9223000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16544000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
189000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
23129000 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
7878000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2280000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2831000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3796000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
229000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
226000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
116523000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
140042000 usd
CY2023Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
431569000 usd
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
440569000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
62919000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
62784000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13091000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13806000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2156000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2213000 usd
CY2023Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
29091000 usd
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
26814000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
655349000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
686228000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0667
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0667
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32225627 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32225627 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32152787 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32152787 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2150000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2145000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
132210000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
128806000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
837197000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
814487000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1859000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7154000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
973416000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
938284000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1628765000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1624512000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232540000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228867000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
159370000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
157361000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
73170000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
71506000 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
18183000 usd
CY2022Q1 us-gaap Selling Expense
SellingExpense
16985000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3450000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3231000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17129000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12954000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
38762000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
33170000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
34408000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
38336000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5565000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-545000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
276000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-161000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-511000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
1573000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5289000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-706000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
29119000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37630000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6409000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8700000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22710000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
28930000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22710000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
28930000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9424000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2842000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
100000 usd
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-27000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9013000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1296000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31723000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27634000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
938284000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22710000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9013000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
3849000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7258000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
973416000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
877015000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
28930000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1296000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
34599000 usd
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
10000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3642000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
873682000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22710000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
28930000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13646000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11928000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4770000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3077000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-203000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
328000 usd
CY2023Q1 bcpc Unrealized Gain Loss On Foreign Currency Transactions And Deferred Compensation
UnrealizedGainLossOnForeignCurrencyTransactionsAndDeferredCompensation
349000 usd
CY2022Q1 bcpc Unrealized Gain Loss On Foreign Currency Transactions And Deferred Compensation
UnrealizedGainLossOnForeignCurrencyTransactionsAndDeferredCompensation
-37000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
968000 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
29000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1600000 usd
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-403000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20405000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5145000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17598000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2747000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-487000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5112000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7708000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5540000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8522000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
662000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-548000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
34838000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7021000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
341000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
9720000 usd
CY2022Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
10256000 usd
CY2023Q1 bcpc Proceeds From Insurance And Sale Of Assets
ProceedsFromInsuranceAndSaleOfAssets
0 usd
CY2022Q1 bcpc Proceeds From Insurance And Sale Of Assets
ProceedsFromInsuranceAndSaleOfAssets
184000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10061000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10072000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
13000000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
20000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
22000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
55000 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
41000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2453000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
498000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
22867000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
20703000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3849000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
34599000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33318000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34845000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2180000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-877000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6361000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38773000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66560000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103239000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60199000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64466000 usd
CY2023Q1 us-gaap Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
14130000 usd
CY2023Q1 us-gaap Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual
BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
-3909000 usd
CY2023Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
232540000 usd
CY2023Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
25570000 usd
CY2022Q1 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
247368000 usd
CY2022Q1 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
29439000 usd
CY2022Q1 bcpc Treasury Stock Shares Acquired And Reissued
TreasuryStockSharesAcquiredAndReissued
245685 shares
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3682000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2379000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
224755 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1045000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
99.82
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
27221000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
109000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
138.09
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
31000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
79.27
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
128.27
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1120000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
104.04
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29327000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y6M
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
743000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
88.07
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
28781000 usd
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
867000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
88.19
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
69711000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
109000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
138.07
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
63.52
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
968000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
94.01
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
41483000 usd
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
676000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
81.06
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
37594000 usd
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y7M6D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.91
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.26
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1584000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
654000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
30507000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
23131000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2023Q1 bcpc Estimated Share Based Compensation Expense Remainder Of Fiscal Year
EstimatedShareBasedCompensationExpenseRemainderOfFiscalYear
15600000 usd
CY2023Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3763038 shares
CY2023Q1 bcpc Stock Repurchase Program Aggregate Number Of Shares Repurchased Since Inception
StockRepurchaseProgramAggregateNumberOfSharesRepurchasedSinceInception
3098657 shares
CY2023Q1 bcpc Treasury Stock Shares Acquired And Reissued
TreasuryStockSharesAcquiredAndReissued
28109 shares
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
136.94
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
140.83
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
37652000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
44477000 usd
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
17054000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3143000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
70062000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
72048000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
124768000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
119668000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
472186000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
460838000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
196083000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
189483000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
276103000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
271355000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
774361000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
769509000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
476310000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
266840000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
472703000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
259408000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7293000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5911000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
20858000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
19047000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15615000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
15473000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14987000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
14591000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q1 bcpc Equity Method Investment Number Of Votes
EquityMethodInvestmentNumberOfVotes
2 vote
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1246000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1317000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
71000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22710000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
28930000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32078000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32041000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
337000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
434000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32415000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32475000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.90
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
509785 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
113029 shares
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.220
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5815000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5815000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1735000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1735000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 us-gaap Assets
Assets
1628765000 usd
CY2022Q4 us-gaap Assets
Assets
1624512000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232540000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228867000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
29119000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
37630000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13646000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11928000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9612000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9709000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232540000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228867000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232540000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
228867000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
42000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
6691000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1010000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9013000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1296000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
9013000 usd
CY2020 bcpc Number Of Savings Plans
NumberOfSavingsPlans
2 plan
CY2021Q1 bcpc Number Of Savings Plans
NumberOfSavingsPlans
1 plan
CY2023Q1 bcpc Defined Benefit Plan Number Of Benefit Plans
DefinedBenefitPlanNumberOfBenefitPlans
2 plan
CY2023Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
9336000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
9320000 usd
CY2023Q1 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
16000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
8543000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
8527000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
16000 usd
CY2023Q1 bcpc Financial Instruments Number Of Financial Instruments Held For Trading Purposes
FinancialInstrumentsNumberOfFinancialInstrumentsHeldForTradingPurposes
0 financial_instrument
CY2023Q1 bcpc Lessee Operating Lease Remaining Renewal Lease Term Reasonable Threshold Period
LesseeOperatingLeaseRemainingRenewalLeaseTermReasonableThresholdPeriod
P2Y
CY2023Q1 bcpc Lessee Operating Lease Number Of Tranches
LesseeOperatingLeaseNumberOfTranches
4 tranche
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
2385000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
2439000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15232000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17094000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
2281000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
2338000 usd
CY2023Q1 bcpc Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
17513000 usd
CY2022Q4 bcpc Operating And Finance Lease Right Of Use Asset
OperatingAndFinanceLeaseRightOfUseAsset
19432000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2831000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3796000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
229000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
226000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
3060000 usd
CY2022Q4 bcpc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
4022000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13091000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13806000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2156000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2213000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
15247000 usd
CY2022Q4 bcpc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
16019000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1270000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
781000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
60000 usd
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
52000 usd
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
29000 usd
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
31000 usd
CY2023Q1 bcpc Finance Lease Cost
FinanceLeaseCost
89000 usd
CY2022Q1 bcpc Finance Lease Cost
FinanceLeaseCost
83000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
1359000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
864000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1058000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
801000 usd
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
29000 usd
CY2022Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
31000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
55000 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
41000 usd
CY2023Q1 bcpc Cash Payments For Operating And Finance Leases
CashPaymentsForOperatingAndFinanceLeases
1142000 usd
CY2022Q1 bcpc Cash Payments For Operating And Finance Leases
CashPaymentsForOperatingAndFinanceLeases
873000 usd
CY2023Q1 bcpc Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Right Of Use Assets Sold
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfRightOfUseAssetsSold
457000 usd
CY2022Q1 bcpc Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Right Of Use Assets Sold
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfRightOfUseAssetsSold
662000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y5M1D
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid Year Two
OperatingAndFinanceLeaseLiabilityToBePaidYearTwo
3286000 usd
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10D
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9Y8M23D
CY2022Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M28D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.037
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.033
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.050
CY2022Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.051
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1270000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
781000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilityToBePaidRemainderOfFiscalYear
4192000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid Year One
OperatingAndFinanceLeaseLiabilityToBePaidYearOne
4320000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid Year Three
OperatingAndFinanceLeaseLiabilityToBePaidYearThree
2774000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid Year Four
OperatingAndFinanceLeaseLiabilityToBePaidYearFour
2309000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid Year Five
OperatingAndFinanceLeaseLiabilityToBePaidYearFive
2024000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid After Year Five
OperatingAndFinanceLeaseLiabilityToBePaidAfterYearFive
4859000 usd
CY2023Q1 bcpc Operating And Finance Lease Liability To Be Paid
OperatingAndFinanceLeaseLiabilityToBePaid
23764000 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
3964000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
5993000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1532000 usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2696000 usd

Files In Submission

Name View Source Status
bcpc-20230331_def.xml Edgar Link unprocessable
0001628280-23-014088-index-headers.html Edgar Link pending
0001628280-23-014088-index.html Edgar Link pending
0001628280-23-014088.txt Edgar Link pending
0001628280-23-014088-xbrl.zip Edgar Link pending
bcpc-20230331.htm Edgar Link pending
bcpc-20230331.xsd Edgar Link pending
bcpcq1202310qex311.htm Edgar Link pending
bcpcq1202310qex312.htm Edgar Link pending
bcpcq1202310qex321.htm Edgar Link pending
bcpcq1202310qex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
bcpc-20230331_cal.xml Edgar Link unprocessable
bcpc-20230331_lab.xml Edgar Link unprocessable
bcpc-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bcpc-20230331_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending